Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00244)

DIG Name
Calcium stearate
Synonyms
CALCIUM STEARATE; 1592-23-0; Octadecanoic acid, calcium salt; Calcium octadecanoate; Calcium distearate; Stearates; Stearic acid calcium salt; UNII-776XM7047L; Stearic acid, calcium salt; 66071-81-6; Flexichem; 776XM7047L; Aquacal; Flexichem CS; calcium dioctadecanoate; Stavinor 30; Calcium bis(stearate); Nopcote C 104; Witco G 339S; HSDB 905; Calcium stearate, 6.4 to 7.4% (Ca), powder; Calcium distearate, pure; EINECS 216-472-8; G 339S; G 339 S; Calcium stearate [JAN:NF]; AI3-01335; Hydrogenated tallow fatty acids calcium salts; Fatty acids, tallow, hydrogenated, calcium salts; EINECS 266-106-6; Stearic acid calcium; Calcium Stearate TCG; Calcium Stearate TCP; calcium stearate powder; Octadecanoic acid, calcium salt (2:1); ACMC-209djm; Lubimax Calcium Stearate; Rashayan Calcium Stearate; Calcium Stearate H-NRML; Calcium Stearate NF/FCC; Hydrogenated tallow fatty acids, calcium salt; Tallow fatty acids, hydrogenated, calcium salt; SCHEMBL2371; Fatty acids, tallow, hydrogenated, calcium salt; C36H70CaO4; Calcium stearate (JP17/NF); CHEMBL2106092; DTXSID7027419; Calcium Stearate (technical grade); ANW-21824; AKOS015915024; DB-023015; FT-0623411; S0236; D03310; Fatty acids, tallow,hydrogenated, calcium salts; A810010; Q423318; UNII-CCH27F55X0 component CJZGTCYPCWQAJB-UHFFFAOYSA-L
DIG Function
lubricant
Formula
C36H70CaO4
Canonical SMILES
CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Ca+2]
InChI
1S/2C18H36O2.Ca/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2*2-17H2,1H3,(H,19,20);/q;;+2/p-2
InChIKey
CJZGTCYPCWQAJB-UHFFFAOYSA-L
Physicochemical Properties Molecular Weight 607 Topological Polar Surface Area 80.3
XlogP N.A. Complexity 196
Heavy Atom Count 41 Rotatable Bond Count 30
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

39 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetazolamide DM1AF5U Absence epilepsy [] Acetazolamide 250 mg tablet F00470
Altretamine DMKLAYG Ovarian cancer [2C73] Altretamine 50 mg capsule F00915
Amifampridine DMK08L3 LambertEaton myasthenic syndrome [8C62] Amifampridine 10 mg tablet F23619
Aripiprazole DM3NUMH Bipolar I disorder [] Aripiprazole 10 mg tablet F01385
Benzphetamine DMIJATC Obesity [5B81] Benzphetamine 50 mg tablet F02393
Caffeine DMKBJWP Allergic rhinitis [CA08.0] Caffeine 200 mg tablet F03103
Chloroquine DMSI5CB Malaria [1F40-1F45] Chloroquine 250 mg tablet F04002
Chlorthalidone DM4DMBT Edema [MG29] Chlorthalidone 25 mg tablet F04088
Diazepam DM08E9O Alcohol withdrawal [] Diazepam 10 mg tablet F05651
Ethacrynic acid DM60QMR Edema [MG29] Ethacrynic acid 25 mg tablet F07683
Framycetin DMF8DNE Acute liver failure [DB91] Neomycin 500 mg tablet F15156
Gabapentin DM6T924 Complex partial seizure [8A68.0] Gabapentin 600 mg tablet F08939
Gemfibrozil DMD8Q3J Hyperlipidaemia [5C80] Gemfibrozil 600 mg tablet F09089
Glycopyrrolate DM2M3ZA Anaesthesia [9A78.6] Glycopyrrolate 1 mg tablet F09372
Griseofulvin DMK54YG Onychomycosis [EE12.1] Griseofulvin 250 mg tablet F09400
Haloperidol DM96SE0 Delirium [] Haloperidol 20 mg tablet F09548
Hydrochlorothiazide DMUSZHD Chronic heart failure [BD1Z] Hydrochlorothiazide 12.5 mg tablet F09674
Hydrocortisone DMGEMB7 Acne vulgaris [ED80] Hydrocortisone 10 mg tablet F09786
Irbesartan DMTP1DC Diabetic kidney disease [GB61.Z] Irbesartan 150 mg tablet F10674
Isoniazid DM5JVS3 Latent tuberculosis infection [] Isoniazid 100 mg tablet F10751
Isosorbide Mononitrate DMYLMU0 Angina pectoris [BA40] Isosorbide mononitrate 10 mg tablet F10809
Lofexidine DM1WXA6 Heroin and opiate withdrawal [6C43] Lofexidine 0.18 mg tablet F23214
Meclizine DMS7T13 Dizziness [MB48] Meclizine 25 mg tablet F12783
Methylprednisolone DM4BDON Acute adrenal insufficiency [] Methylprednisolone 32 mg tablet F13644
Metoprolol DMOJ0V6 Acute coronary syndrome [BA41] Metoprolol 100 mg tablet F13726
Nilutamide DMFN07X Prostate cancer [2C82.0] Nilutamide 150 mg tablet F15374
Nitroglycerin DMQ2491 Angina pectoris [BA40] Nitroglycerin 0.3 mg tablet F15451
Ondansetron DMOTQ1I Chemotherapy-induced nausea [MD90] Ondansetron 4 mg tablet F15952
Orphenadrine DMW542E Parkinson disease [8A00.0] Orphenadrine 100 mg tablet F16041
Pantoprazole DMSVOCZ Gastrinoma [2C10.1] Pantoprazole 20 mg tablet F16513
Phenobarbital DMXZOCG Cluster headache [8A81.0] Phenobarbital 15 mg tablet F17056
Pimozide DMW83TP Schizophrenia [6A20] Pimozide 1 mg tablet F17267
Potassium Chloride DMMTAJC Hypokalemia [5C77] Potassium chloride 10 meq capsule F17372
Pravastatin DM6A0X7 Adult acute monocytic leukemia [] Pravastatin 10 mg tablet F17623
Quinine DMSWYF5 Malaria [1F40-1F45] Quinine 200 mg tablet F18646
Rifapentine DMCHV4I Pulmonary tuberculosis [1B10.Z] Rifapentine 150 mg tablet F18989
Risperidone DMN6DXL Bipolar I disorder [] Risperidone 0.5 mg tablet F19079
Sodium phenylbutyrate DMXLBCQ Spinal muscular atrophy [8B61] Sodium phenylbutyrate 500 mg tablet F20311
Tamsulosin DM5QF9V Benign prostatic hyperplasia [GA90] Tamsulosin 0.4 mg capsule F20645
------------------
⏷ Show the Full List of 39 Approved Drug(s)
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Obsolete neurogenic bladder [] Oxybutynin 5 mg tablet F16205
------------------